Terazosin Hydrochloride
- Product NDC
- 70518-0821
- 11-digit product format
- 705180821
- Labeler code
- 70518
- Product ID
- 70518-0821_8edb3ffe-fe41-a3af-e053-2a95a90a4701
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA074823
- Marketing category
- ANDA
- Marketing start
- 2017-11-06
- Marketing end
- 0000-00-00
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record